Morningstar

Insulet Corp PODD

Morningstar Rating
Unlock
Stock XNAS Rating as of
$232.03 −3.40 (1.44%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Price vs Fair Value

View History
PODD is trading at a 893% premium.
Price
$232.03
Fair Value
$847.00
Uncertainty
High
1-Star Price
$835.54
5-Star Price
$477.00
Economic Moat
Hctyx
Capital Allocation
Gzckvljhs

Bulls Say, Bears Say

Bulls

We see global growth for the insulin pump market, as Type 1 diabetics embrace continuous subcutaneous insulin infusion therapy for its lower rate of long-term diabetes-related complications.

Bears

With only one product and low switching costs for customers, Insulet is very vulnerable if larger competitors produce similar or superior tubeless insulin pumps.

Show More

News

View All

Trading Information

Previous Close Price
$235.43
Day Range
$231.89–238.40
52-Week Range
$125.82–243.98
Bid/Ask
$217.49 / $238.00
Market Cap
$16.27 Bil
Volume/Avg
518,736 / 726,154

Key Statistics

Price/Earnings (Normalized)
68.45
Price/Sales
9.35
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
—

Company Profile

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Growth
Total Number of Employees
3,000
Website
https://www.insulet.com

Competitors

Valuation

View More
Metric
PODD
DXCM
MDT
Price/Earnings (Normalized)
 68.4538.4517.05
Price/Book Value
 16.2911.082.39
Price/Sales
 9.357.193.62
Price/Cash Flow
 44.0331.4515.81
Price/Earnings
PODD
DXCM
MDT

Financial Strength

Metric
PODD
DXCM
MDT
Quick Ratio
 2.412.391.35
Current Ratio
 3.602.822.13
Interest Coverage
 7.0335.337.66
Quick Ratio
PODD
DXCM
MDT

Profitability

Metric
PODD
DXCM
MDT
Return on Assets (Normalized)
 9.03%10.74%7.66%
Return on Equity (Normalized)
 31.74%31.84%13.69%
Return on Invested Capital (Normalized)
 11.10%12.04%9.84%
Return on Assets
PODD
DXCM
MDT

Medical Devices Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LgcvsvtRyjczs$195.6 Bil
 Stryker Corp
SYK
RymhzltznsZvclx$137.3 Bil
 Boston Scientific Corp
BSX
HgftdrdvSsyxr$122.7 Bil
 Medtronic PLC
MDT
JpqpljdchWrvxg$114.6 Bil
 Edwards Lifesciences Corp
EW
PqjjcqqflfLyqfzg$40.1 Bil
 Koninklijke Philips NV ADR
PHG
CtcdcDgpz$30.7 Bil
 DexCom Inc
DXCM
WrjmmkrysKxhs$27.0 Bil
 Steris PLC
STE
SgtjpghvYzbmb$23.6 Bil
 Zimmer Biomet Holdings Inc
ZBH
WyxnxhhnhTgsvt$22.0 Bil

Sponsor Center